Invesco Exchange-Traded Self-Indexed Fund Trust has released its latest financial report, revealing total assets of approximately $180 million as of August 31, 2026. This update is significant for the company as it underscores its ongoing commitment to transparency and performance in the investment sector.
The filing, dated October 30, 2026, indicates that the trust's net assets stand at around $175 million, after accounting for liabilities of approximately $4.8 million. This financial disclosure is part of the company's regular reporting obligations under the Investment Company Act of 1940.
Company Background
Invesco Exchange-Traded Self-Indexed Fund Trust, based in Downers Grove, Illinois, is an investment entity that provides a range of exchange-traded funds (ETFs). The trust's focus is on self-indexed strategies, allowing it to offer unique investment opportunities to its clients. The company was previously known as PowerShares Exchange-Traded Self-Indexed Fund Trust before its name change in 2015.
What the Filing Says
The recent filing, accession number 0001657201-26-000797, provides detailed information about the fund's financial status. It states, "Total assets amount to $180,109,525.31, with net assets of $175,275,757.25." This data reflects the trust's current standing and its operational health.
Impact
This update may affect various stakeholders, including investors, financial analysts, and competitors within the investment management industry. Investors may view the trust's financial health as a positive indicator of its performance and stability, potentially influencing their investment decisions.
What's Next
The filing does not say what happens next. However, the trust is expected to continue its regular reporting and may provide further updates in subsequent filings.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






